5:38 PM
 | 
Feb 20, 2013
 |  BC Extra  |  Top Story

Merck, Samsung Bioepis in biosimilars deal

Merck & Co. Inc. (NYSE:MRK) partnered with Samsung Bioepis Co. Ltd. to develop and commercialize multiple, prespecified but undisclosed biosimilars. Samsung Bioepis, a JV between Biogen Idec Inc. (NASDAQ:BIIB) and Samsung...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >